HTR5A and amyotrophic lateral sclerosis: Studies in ALS patients and transgenic (TG) ALS mice have shown an increase in energy expenditure during the course of disease (Desport et al., 2001; Funalot et al., 2009), which is similar to the chronic depletion effect of brain-derived 5-HT (Yadav et al., 2009).